<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01990027</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-2013-0330</org_study_id>
    <nct_id>NCT01990027</nct_id>
  </id_info>
  <brief_title>Swiss Kidney Stone Cohort (SKSC)</brief_title>
  <acronym>SKSC</acronym>
  <official_title>Swiss Kidney Stone Cohort (SKSC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Swiss National Centre of Competence in Research Kidney Control of Homeostasis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Swiss National Centre of Competence in Research Kidney Control of Homeostasis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SKSC is a continuous database with the objective of a standardized diagnosis and
      monitoring of patients with kidney stones as well as the establishment of a Biobank.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is multi-site, standardized observation and characterization of
      kidney stone patients.

      Furthermore, an adequate structure should be established for the execution of studies with
      kidney stone patients, in order to then, if necessary, develop recommendations for useful
      monitoring or prophylactic measures, as well as new treatment options for kidney stone
      patients.

      A control group of 250 stone-free volunteers matching patients cohort participants for sex
      and age started recruitment in October 2017 and will serve the purpose of comparison in
      future studies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2024</completion_date>
  <primary_completion_date type="Anticipated">April 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Epidemiological characterization</measure>
    <time_frame>10 years</time_frame>
    <description>Epidemiological characterization of kidney stone patients</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1250</enrollment>
  <condition>Kidney Stone</condition>
  <arm_group>
    <arm_group_label>SKSC Patients group</arm_group_label>
    <description>A group a 1000 subjects affected by kidney stone as described in the eligibility criteria will be recruited in the period 2014-2024 and the same exams will be repeated for each participants for a period of 3 years.
No intervention will be undertaken.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SKSC Control group</arm_group_label>
    <description>A group of 250 stone-free participants will be recruited and analysed with the same protocol as the patients but in a single visit. This group will be used for comparison with the patients group in future studies.
No intervention will be undertaken.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood; plasma; serum; urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a kidney stone episode + Kidney stone-free control group
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        For SKSC Patients Group:

        Inclusion Criteria:

        Only patients that meet all of the following inclusion criteria can be included in this
        study:

          -  Signed Declaration of informed consent

          -  Male or female

          -  Recurrent kidney stone episodes (more than 1) or an individual kidney stone episode
             with one or several of the following risk factors:

          -  The first manifestation at the a minimum age of 25

          -  Positive family history

          -  Non-calcium oxalate stones

          -  Gastrointestinal disorders (e.g. gastric bypass surgery, inflammatory bowel disease,
             malabsorption etc.)

          -  Osteoporosis

          -  Nephrocalcinosis

          -  Single kidneyness

          -  Currently pregnant

          -  Gout

          -  Metabolic syndrome ( Diabetes Mellitus type I and II )

          -  Residual calculi (at least 3 months after the therapy)

          -  Bilateral or multiple stones

          -  Chronic urinary tract infection

          -  Chronic renal failure (eGFR lower than 60 ml/min.)

          -  Kidney transplant

        Exclusion Criteria:

        Patients with at least one of the following exclusion criteria may not take part in this
        study.

          -  Not signed Informed Consent form

          -  Age below 18 years old

        For SKSC Control Group

        Inclusion criteria:

          -  Signed Declaration of informed consent

          -  Male or female

          -  Kidney-stone free (screening verification by low-dose CT-scan)

        Exclusion criteria:

          -  Not signed Informed Consent form

          -  Age below 18 years old

          -  Pregnancy

          -  History of kidney stones

          -  Low-dose CT-scan positive for kidney stones during screening phase
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olivier Bonny, MD-PhD</last_name>
    <email>Olivier.Bonny@unil.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carsten Wagner, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HUG</name>
      <address>
        <city>Geneva</city>
        <state>GE</state>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Ernandez, MD</last_name>
      <phone>+41 79 55 33284</phone>
      <email>Thomas.ernandez@hcuge.ch</email>
    </contact>
    <investigator>
      <last_name>Catherine Stoermann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Ernandez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <state>Kanton Aargau</state>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Buchkremer, MD</last_name>
      <phone>+41 62 838 43 06</phone>
      <email>florian.buchkremer@ksa.ch</email>
    </contact>
    <investigator>
      <last_name>Florian Buchkremer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USZ</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>CH-8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nilufar Mohebbi</last_name>
      <phone>+41 44 255 11 11</phone>
    </contact>
    <investigator>
      <last_name>Nilufar Mohebbi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universit√§tsspital Basel</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Inselspital</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Fuster, MD</last_name>
      <phone>+41 31 632 97 72</phone>
      <email>daniel.fuster@ibmm.unibe.ch</email>
    </contact>
    <investigator>
      <last_name>Daniel Fuster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nasser Dhayat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHUV</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Bonny, MD</last_name>
      <phone>+41795564612</phone>
      <email>Olivier.Bonny@unil.ch</email>
    </contact>
    <investigator>
      <last_name>Olivier Bonny, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://nccr-kidney.ch</url>
  </link>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2013</study_first_submitted>
  <study_first_submitted_qc>November 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2013</study_first_posted>
  <last_update_submitted>November 28, 2017</last_update_submitted>
  <last_update_submitted_qc>November 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>kidney stone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

